Dr Reddy''s Laboratories reports an 86% drop in Q4 profit due to lower North America generics sales. FY26 revenue rises despite challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results